New study finds a cheaper over-the-counter cholesterol medication - KCBD NewsChannel 11 Lubbock

11/16/09

New study finds a cheaper over-the-counter cholesterol medication may be best

Posted:

By Kristin Beerman | email

LUBBOCK, TX (KCBD) – A new study is raising questions about two popular cholesterol-lowering drugs Ytorin and Zetia.  The report shows that a cheaper, over-the-counter medication may work even better than expensive prescription pills.  Researchers presented that on Monday to thousands of doctors at the American Heart Association's annual meeting in Orlando.  They say their findings show that Niacin, a cholesterol lowering drug that happens to be over the counter, is effective in cutting the dangerous plaque in the neck arteries more so than the prescriptions Zetia and Vytorin, which had no effect at all on plaque.  With an estimated nine million patients taking Zetia and Vytori, the study is drawing both criticism and praise.

"In the New England Journal of Medicine, editorials that accompany this study, both commentators caution physicians on the basis of the limitations and the size of the studies, not to draw broad, general conclusions about the clinical effectiveness of Zetia," said Ken Fraier, maker of Zetia and Vytorin.

"There's never been a perfect study. Do we believe the results? Yes, the vast majority of us do believe these results," said Steven Nissen, M.D., a cardiologist.

You should know this was a very small study and if you are taking Zetia or Vytorin you should not stop taking that prescription on your own.  Just talk to your doctor to see if that is still the right course for you.  For more information on these medications please go to clickhere

 

©2009 KCBD NewsChannel 11.  All rights reserved.  This material may not be published, broadcast, rewritten, or redistributed.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.